NANOBIOTIX (NANO.PA) Stock Overview
Europe - EPA:NANO - FR0011341205 - Common Stock
NANO.PA Key Statistics, Chart & Performance
The current stock price of NANO.PA is 8.51 EUR. In the past month the price increased by 6.71%. In the past year, price increased by 76.27%.
NANO.PA Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| 4AB.DE | ABBVIE INC | 20.42 | 324.69B | ||
| AMG.DE | AMGEN INC | 12.47 | 124.44B | ||
| GIS.DE | GILEAD SCIENCES INC | 14.42 | 117.77B | ||
| 1VRTX.MI | VERTEX PHARMACEUTICALS INC | 23.24 | 85.81B | ||
| VX1.DE | VERTEX PHARMACEUTICALS INC | 23.23 | 85.76B | ||
| 1AE.DE | ARGENX SE | 86.89 | 39.03B | ||
| ARGX.BR | ARGENX SE | 85.91 | 38.59B | ||
| 22UA.DE | BIONTECH SE-ADR | N/A | 20.15B | ||
| 1BIIB.MI | BIOGEN INC | 9.3 | 18.55B | ||
| IDP.DE | BIOGEN INC | 8.93 | 17.81B | ||
| 1EXEL.MI | EXELIXIS INC | 18.75 | 8.93B | ||
| 0QF.DE | MODERNA INC | N/A | 8.17B |
Related stock screener links
About NANO.PA
Company Profile
Nanobiotix SA is a late-stage biotechnology company, which engages in the development of therapeutic approaches to the treatment of cancer. The company is headquartered in Paris, Ile-De-France and currently employs 108 full-time employees. The company went IPO on 2012-10-29. The firm designs and manufactures nanoparticles that safely enhance the efficacy of radiation therapy in the treatment of cancer. The company develops new tools for cancer that utilize a physical mode of action at the cellular level of the cancer cell. The firm's NanoXray technology comprises three products. Local treatment (surgery and radiotherapy) provides potential cure and gives the systemic treatment a better chance to life expectancy. NanoXray products are developed for the efficacy of radiotherapy in the tumor cell. Nanobiotix is a spin-off of the State University of New York (SUNY) at Buffalo.
Company Info
NANOBIOTIX
60 rue de Wattignies
Paris ILE-DE-FRANCE FR
Employees: 108
Phone: 33140260470
NANOBIOTIX / NANO.PA FAQ
What is the stock price of NANOBIOTIX today?
The current stock price of NANO.PA is 8.51 EUR. The price increased by 7.04% in the last trading session.
What is the ticker symbol for NANOBIOTIX stock?
The exchange symbol of NANOBIOTIX is NANO and it is listed on the Euronext Paris - Matif exchange.
On which exchange is NANO.PA stock listed?
NANO.PA stock is listed on the Euronext Paris - Matif exchange.
What is the price forecast or stock price prediction for NANOBIOTIX stock?
12 analysts have analysed NANO.PA and the average price target is 11.41 EUR. This implies a price increase of 34.04% is expected in the next year compared to the current price of 8.51. Check the NANOBIOTIX stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is NANOBIOTIX worth?
NANOBIOTIX (NANO.PA) has a market capitalization of 407.81M EUR. This makes NANO.PA a Small Cap stock.
How many employees does NANOBIOTIX have?
NANOBIOTIX (NANO.PA) currently has 108 employees.
What are the support and resistance levels for NANOBIOTIX (NANO.PA) stock?
NANOBIOTIX (NANO.PA) has a support level at 7.77 and a resistance level at 8.43. Check the full technical report for a detailed analysis of NANO.PA support and resistance levels.
Is NANOBIOTIX (NANO.PA) expected to grow?
The Revenue of NANOBIOTIX (NANO.PA) is expected to grow by 5.81% in the next year. Check the estimates tab for more information on the NANO.PA EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy NANOBIOTIX (NANO.PA) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of NANO.PA, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of NANO.PA, evaluating the profitability, health, valuation and growth aspects
- NANOBIOTIX (NANO.PA) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- NANOBIOTIX (NANO.PA) Sales and EPS estimates to see what analysts future expectations are.
- NANOBIOTIX (NANO.PA) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- NANOBIOTIX (NANO.PA) Insider and Institutional Ownership to learn about the owners and their transactions.
- NANOBIOTIX (NANO.PA) Stock Chart to make your own analysis
- NANOBIOTIX (NANO.PA) Latest news and press-releases to stay up to date.
Does NANOBIOTIX (NANO.PA) stock pay dividends?
NANO.PA does not pay a dividend.
When does NANOBIOTIX (NANO.PA) report earnings?
NANOBIOTIX (NANO.PA) will report earnings on 2025-09-16.
What is the Price/Earnings (PE) ratio of NANOBIOTIX (NANO.PA)?
NANOBIOTIX (NANO.PA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.44).
NANO.PA Technical Analysis
ChartMill assigns a technical rating of 9 / 10 to NANO.PA. When comparing the yearly performance of all stocks, NANO.PA is one of the better performing stocks in the market, outperforming 98.2% of all stocks.
NANO.PA Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to NANO.PA. NANO.PA has a bad profitability rating. Also its financial health evaluation is rather negative.
NANO.PA Financial Highlights
Over the last trailing twelve months NANO.PA reported a non-GAAP Earnings per Share(EPS) of -1.44. The EPS decreased by -33.33% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -101.06% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
NANO.PA Forecast & Estimates
12 analysts have analysed NANO.PA and the average price target is 11.41 EUR. This implies a price increase of 34.04% is expected in the next year compared to the current price of 8.51.
For the next year, analysts expect an EPS growth of 41.35% and a revenue growth 5.81% for NANO.PA